Mersana Therapeutics Inc (NAS:MRSN)
$ 2.63 -0.08 (-2.95%) Market Cap: 321.81 Mil Enterprise Value: 156.15 Mil PE Ratio: 0 PB Ratio: 8.48 GF Score: 39/100

Mersana Therapeutics Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 12, 2022 / 08:15PM GMT
Release Date Price: $7.48 (-4.10%)
Unidentified Analyst

Hello, everyone. Apologies for the late delay here. I'm clearly not Albert Wong. My name is (inaudible), and I'm a Vice President of Investment Banking at Morgan Stanley. Before we get started, I just need to read the quick research disclosure. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.

So I would love to introduce Anna and Brian, CEO and CFO of the company. Welcome, guys. Thank you for joining us.

Anna Protopapas
Mersana Therapeutics, Inc. - President, CEO & Director

Thank you for having us.

Unidentified Analyst

So before we get started, anything you'd like to say to the audience?

Anna Protopapas
Mersana Therapeutics, Inc. - President, CEO & Director

Yes. This is a very exciting

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot